Click a link below to view the mailing archive as if it had been sent to you.
| 2019-08-31 00:15 | | When FDA Can Accept Greater Premarket Uncertainty for Medical Devices and more... |
| 2019-08-30 12:15 | | State attorneys general dubious about Purdue's reported $12B opioid settlement offer: WSJ and more... |
| 2019-08-30 00:15 | | Three strategies for managing loss of exclusivity successfully and more... |
| 2019-08-29 12:15 | | $5.8B for Nothing: AbbVie Shelves Stemcentryx Drug After Latest Flop and more... |
| 2019-08-29 00:15 | | FDA issues safety warning for newer hepatitis C drugs following patient deaths and more... |
| 2019-08-28 12:15 | | Amgen puts out welcome mat for Celgene’s Otezla reps, but will they join—and then stay? and more... |
| 2019-08-28 00:15 | | Report: Purdue Pharma Offered $10-12 Billion To Settle Thousands Of Opioid Lawsuits and more... |
| 2019-08-27 12:15 | | Don't give up yet on biosimilars, Gottlieb says. Congress could give them a boost and more... |
| 2019-08-27 00:15 | | Celgene's $13.4 Billion Deal With Amgen Is a Win-Win-Win and more... |
| 2019-08-26 12:15 | | Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger and more... |
| 2019-08-26 00:15 | | Companies file suit in Canada challenging new rules to lower drug prices and more... |
| 2019-08-24 12:15 | | AI And Healthcare: Is The Bloom Finally Off The Rose? and more... |
| 2019-08-24 00:15 | | Should J&J owe billions for Oklahoma's opioid crisis? We'll find out Monday and more... |
| 2019-08-23 12:15 | | HHS pledges $23M to develop Merck's experimental Ebola vaccine and more... |
| 2019-08-23 00:15 | | Biotech Giant Amgen Could Be Nearing A Massive Takeover: Report and more... |
| 2019-08-22 12:15 | | AstraZeneca pays Sobi $95M for priority review voucher and more... |
| 2019-08-22 00:15 | | 5 More Private Medtech Companies to Watch and more... |
| 2019-08-21 12:15 | | Could a 'creative deal' between Perrigo, Amneal help reinvent both struggling businesses? and more... |
| 2019-08-21 00:15 | | Report: Prices for Branded Drugs Continue to Increase, but at Slower Pace and more... |
| 2019-08-20 12:15 | | Explaining Medicare Part D's Success As A Byproduct Of Flat Voucher Subsidies and more... |
| 2019-08-20 00:15 | | Sarepta Duchenne drug rejected by FDA in surprise decision and more... |
| 2019-08-19 12:15 | | Is Pfizer's established drugs' decline in China the ‘canary in the coalmine?’ and more... |
| 2019-08-19 00:15 | | What happened a year ago this week in biopharma? August 12-18, 2018 and more... |
| 2019-08-18 00:15 | | FDA Approval 'Finally' Recognizes Vertebral Body Tethering as a Mainstream Scoliosis Treatment and more... |
| 2019-08-17 12:15 | | Price, safety will test blockbuster billing for AbbVie's new arthritis drug and more... |
| 2019-08-17 00:15 | | Ahead of FDA decisions on one antibiotic, Nabriva plans resubmission of another and more... |
| 2019-08-16 12:15 | | Alector, Prevail trade blows over alleged misuse of confidential information and more... |
| 2019-08-16 00:15 | | Four New Drugs are Around the Corner. Here’s What You Need to Know. and more... |
| 2019-08-15 12:15 | | China has become a CEO-level priority for multinational pharmaceutical companies: the trend and the implications and more... |
| 2019-08-15 00:15 | | FDA approves TB pill that cures more hard-to-treat patients and more... |
| 2019-08-14 12:15 | | AveXis scientific founder is out as Novartis names a new CSO in wake of an ethics scandal and more... |
| 2019-08-14 00:15 | | Table for two: AbbVie was Allergan's only suitor in $63B takeover that shocked the industry and more... |
| 2019-08-13 12:15 | | 5 Biggest New Drugs Approved in 2019 So Far and more... |
| 2019-08-13 00:15 | | To Find The Next Antibiotic, Scientists Give Old Drugs A New Purpose and more... |
| 2019-08-12 12:15 | | What Enbrel needs to do after its patent win and more... |
| 2019-08-12 00:15 | | AnaptysBio Prepares for a Potential Gear Shift |
| 2019-08-11 00:15 | | Enbrel ruling lifts Amgen shares and more... |
| 2019-08-10 00:15 | | 89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team and more... |
| 2019-08-09 12:15 | | Canadian Government Takes U.S. and Switzerland Off Drug Pricing Comparison List, Pushes for More Transparency and more... |
| 2019-08-09 00:15 | | DBV Technologies Resubmits BLA for Peanut Allergy Treatment and more... |
| 2019-08-08 12:15 | | Whoops! Allergan's bid to shield Botox manufacturing secrets from competitors backfires and more... |
| 2019-08-08 00:15 | | Novartis resolute that it acted in good faith on Zolgensma and more... |
| 2019-08-07 12:15 | | Novartis used manipulated data in winning Zolgensma approval, FDA says and more... |
| 2019-08-07 00:15 | | AbbVie’s $63B Allergan buyout offer depends on Botox growth. But will it last? and more... |
| 2019-08-06 12:15 | | BioMarin's Roller Coaster Continues and more... |
| 2019-08-06 00:15 | | Sanofi ends partnership with Lexicon after trial failure and more... |
| 2019-08-05 12:15 | | Daiichi Sankyo scores landmark FDA OK for rare tumor drug — albeit with restrictions and more... |
| 2019-08-05 00:15 | | Will This Asteroid Heading Toward Vertex Pharmaceuticals Make Impact? and more... |
| 2019-08-04 00:15 | | Mylan-Upjohn Merger Leaves Analysts Skeptical and more... |
| 2019-08-03 12:15 | | Purdue Pharma seeks to minimize its role in opioid crisis as it urges dismissal of Massachusetts suit |
| 2019-08-03 00:15 | | Novo extends R&D alliance with AI specialist e-Therapeutics and more... |
| 2019-08-02 12:15 | | RAPT Therapeutics Postpones $86 Million IPO and more... |
| 2019-08-01 12:15 | | GSK split edges closer as OTC joint venture deal with Pfizer closes and more... |
| 2019-08-01 00:15 | | Sunovion announces acceptance by FDA of NDA for Dasotraline to treat Binge Eating Disorder and more... |
